Literature DB >> 19657990

Late effects of treatment for wilms tumor.

Karen D Wright1, Daniel M Green, Najat C Daw.   

Abstract

Advancements in surgery, radiotherapy, and chemotherapy have greatly improved the cures rates for children with Wilms tumor. However, a number of therapy-related late effects have been observed in long-term survivors. Generally, late complications are a consequence of treatment type and intensity; the use of radiotherapy and anthracyclines increases the risk of these complications. This commentary highlights some clinically significant late sequelae-musculoskeletal effects, cardiac toxicity, reproductive problems, renal dysfunction, and the development of second malignant neoplasms. Careful medical and epidemiological monitoring of survivors can provide critical information to further optimize therapy while minimizing long-term sequelae.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657990      PMCID: PMC2829307          DOI: 10.3109/08880010903019344

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  47 in total

1.  Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer.

Authors:  A M Goorin; A R Chauvenet; A R Perez-Atayde; J Cruz; R McKone; S E Lipshultz
Journal:  J Pediatr       Date:  1990-01       Impact factor: 4.406

2.  Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation.

Authors:  M M Hawkins; R A Smith
Journal:  Int J Cancer       Date:  1989-03-15       Impact factor: 7.396

3.  Cardiac transplantation in childhood cancer survivors in Great Britain.

Authors:  G Levitt; K Bunch; C A Rogers; B Whitehead
Journal:  Eur J Cancer       Date:  1996-05       Impact factor: 9.162

Review 4.  Epidemiology of Wilms tumor.

Authors:  N Breslow; A Olshan; J B Beckwith; D M Green
Journal:  Med Pediatr Oncol       Date:  1993

5.  Cardiac toxicity 4 to 20 years after completing anthracycline therapy.

Authors:  L J Steinherz; P G Steinherz; C T Tan; G Heller; M L Murphy
Journal:  JAMA       Date:  1991-09-25       Impact factor: 56.272

6.  Spinal deformity induced by radiotherapy for solid tumours in childhood: a long-term follow up study.

Authors:  A Mäkipernaa; J T Heikkilä; J Merikanto; E Marttinen; M A Siimes
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

7.  Cardiac function in Wilms' tumor survivors.

Authors:  K Sorensen; G Levitt; D Sebag-Montefiore; C Bull; I Sullivan
Journal:  J Clin Oncol       Date:  1995-07       Impact factor: 44.544

8.  Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group.

Authors:  N E Breslow; J R Takashima; J A Whitton; J Moksness; G J D'Angio; D M Green
Journal:  J Clin Oncol       Date:  1995-08       Impact factor: 44.544

9.  Ovarian failure following abdominal irradiation in childhood: natural history and prognosis.

Authors:  W H Wallace; S M Shalet; E C Crowne; P H Morris-Jones; H R Gattamaneni
Journal:  Clin Oncol (R Coll Radiol)       Date:  1989-11       Impact factor: 4.126

10.  Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer.

Authors:  M M Hawkins; L M Wilson; H S Burton; M H Potok; D L Winter; H B Marsden; M A Stovall
Journal:  J Natl Cancer Inst       Date:  1996-03-06       Impact factor: 13.506

View more
  18 in total

Review 1.  Current management of wilms' tumor.

Authors:  Leah Nakamura; Michael Ritchey
Journal:  Curr Urol Rep       Date:  2010-02       Impact factor: 3.092

2.  Peptide spectra in Wilms tumor that associate with adverse outcomes.

Authors:  Andrew Jackson Murphy; Janene Pierce; Erin H Seeley; Lisa M Sullivan; Eduardo D Ruchelli; Michael L Nance; Richard M Caprioli; Harold N Lovvorn
Journal:  J Surg Res       Date:  2015-03-18       Impact factor: 2.192

3.  Expression and prognostic value of the Ki-67 in Wilms' tumor: experience with 48 cases.

Authors:  Ivo Jurić; Zenon Pogorelić; Ivana Kuzmić-Prusac; Mihovil Biocić; Gordana Jakovljević; Jasminka Stepan; Bozidar Zupancić; Srdana Culić; Bozo Kruslin
Journal:  Pediatr Surg Int       Date:  2010-03-20       Impact factor: 1.827

4.  Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.

Authors:  Conrad V Fernandez; Elizabeth A Mullen; Yueh-Yun Chi; Peter F Ehrlich; Elizabeth J Perlman; John A Kalapurakal; Geetika Khanna; Arnold C Paulino; Thomas E Hamilton; Kenneth W Gow; Zelig Tochner; Fredric A Hoffer; Janice S Withycombe; Robert C Shamberger; Yeonil Kim; James I Geller; James R Anderson; Paul E Grundy; Jeffrey S Dome
Journal:  J Clin Oncol       Date:  2017-12-06       Impact factor: 44.544

Review 5.  Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example.

Authors:  Rachel Shukrun; Naomi Pode Shakked; Benjamin Dekel
Journal:  Pediatr Nephrol       Date:  2013-06-13       Impact factor: 3.714

Review 6.  Position paper: Rationale for the treatment of children with CCSK in the UMBRELLA SIOP-RTSG 2016 protocol.

Authors:  Saskia L Gooskens; Norbert Graf; Rhoikos Furtwängler; Filippo Spreafico; Christophe Bergeron; Gema L Ramírez-Villar; Jan Godzinski; Christian Rübe; Geert O Janssens; Gordan M Vujanic; Ivo Leuschner; Aurore Coulomb-L'Hermine; Anne M Smets; Beatriz de Camargo; Sara Stoneham; Harm van Tinteren; Kathy Pritchard-Jones; Marry M van den Heuvel-Eibrink
Journal:  Nat Rev Urol       Date:  2018-02-27       Impact factor: 14.432

7.  Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Authors:  Esmee Cm Kooijmans; Arend Bökenkamp; Nic S Tjahjadi; Jesse M Tettero; Eline van Dulmen-den Broeder; Helena Jh van der Pal; Margreet A Veening
Journal:  Cochrane Database Syst Rev       Date:  2019-03-11

8.  Abdominal radiotherapy: a major determinant of metabolic syndrome in nephroblastoma and neuroblastoma survivors.

Authors:  Marjolein van Waas; Sebastian J C M M Neggers; Hein Raat; Caroline M van Rij; Rob Pieters; Marry M van den Heuvel-Eibrink
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

Review 9.  Adult Wilms' tumor - diagnosis and current therapy.

Authors:  Joanna Huszno; Danuta Starzyczny-Słota; Magdalena Jaworska; Elżbieta Nowara
Journal:  Cent European J Urol       Date:  2013-04-26

10.  Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours.

Authors:  Dinesh Rakheja; Kenneth S Chen; Yangjian Liu; Abhay A Shukla; Vanessa Schmid; Tsung-Cheng Chang; Shama Khokhar; Jonathan E Wickiser; Nitin J Karandikar; James S Malter; Joshua T Mendell; James F Amatruda
Journal:  Nat Commun       Date:  2014-09-05       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.